A tetravalent Shigella outer membrane vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice
- 22 January 2023
- journal article
- research article
- Published by Elsevier in Microbes and Infection
- Vol. 25 (5) , 105100
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India
- Indian Council of Medical Research
This publication has 45 references indexed in Scilit:
- Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus ProteinsInfection and Immunity, 2012
- Effects of adjuvants on IgG subclasses elicited by virus-like ParticlesJournal of Translational Medicine, 2012
- Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane VesiclesAnnual Review of Microbiology, 2010
- Th17 Cells Are the Dominant T Cell Subtype Primed by Shigella flexneri Mediating Protective ImmunityThe Journal of Immunology, 2010
- Secretory IgA-Mediated Neutralization of Shigella flexneri Prevents Intestinal Tissue Destruction by Down-Regulating Inflammatory CircuitsThe Journal of Immunology, 2009
- Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2aVaccine, 2008
- Molecular Pathogenesis ofShigellaspp.: Controlling Host Cell Signaling, Invasion, and Death by Type III SecretionClinical Microbiology Reviews, 2008
- Structural and genetic evidence that the Escherichia coli O148 O antigen is the precursor of the Shigella dysenteriae type 1 O antigen and identification of a glucosyltransferase geneMicrobiology, 2007
- Community-Based Safety, Immunogenicity, and Transmissibility Study of the Shigella sonnei WRSS1 Vaccine in Israeli VolunteersInfection and Immunity, 2005
- Hypothesis for Vaccine Development: Protective Immunity to Enteric Diseases Caused by Nontyphoidal Salmonellae and Shigellae May Be Conferred by Serum IgG Antibodies to the O-Specific Polysaccharide of Their LipopolysaccharidesClinical Infectious Diseases, 1992